Suggestions

DOC · NYSE

HEALTHPEAK PROPERTIES INC

Private beta

Sector unavailable · Industry unavailable

$20.30

-0.34%

Close on Sep 11, 2026

Insufficient Data

Updated 6/30/2026

Long-term research evidence only. No price targets, no trading signals, no recommendations.

Investment Report Card

HEALTHPEAK PROPERTIES INC

Sector unavailable · Data confidence limited

No Suggested Investment Score today

Risk Intelligence is unavailable

Risk Intelligence

Core Model

Not Available

Not Scored

How strong and defensively sound is the company?

This reading is not available for this company yet.

Long-Term Potential

Research Model

Not Available

Not Scored

Does the business have the characteristics needed to create value over many years?

This reading is not available for this company yet.

Fundamental Momentum

Research Model

Not Available

Not Scored

Is the underlying business getting stronger or weaker?

This reading is not available for this company yet.

Ownership Intelligence

Supplemental Intelligence

Not Available

Positive disclosed activity

What are important owners actually doing?

This reading is not available for this company yet.

Valuation Intelligence

Research Model
C

65 / 100

Attractive

Is today's price reasonable?

Around the middle of the covered universe — and valuation is researched separately from the Suggested Investment Score.

Capital Returns Intelligence

Research Model
F

39 / 100

Limited Capital Returns

How effectively does the company reward shareholders?

Weaker than most covered companies on this measure — and capital returns are researched separately from the Suggested Investment Score.

Why it stands out

  • More disclosed holders are new or increasing than reducing or exiting.
  • Attractive valuation: the stock reads 65 out of 100 on Valuation Intelligence (Attractive) relative to its own history and comparable companies.

What holds it back

No weakening evidence is recorded in today's readings.

Long-term view

Long-Term Potential is not available for this company, so no long-term reading is shown.

Ownership view

No disclosed ownership reading is available at the required confidence, so ownership is left blank rather than estimated.

Valuation view

HEALTHPEAK PROPERTIES INC reads 65 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and below comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value. Valuation Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.

Capital returns view

HEALTHPEAK PROPERTIES INC reads 39 out of 100 on Capital Returns Intelligence (Limited Capital Returns), reflecting a dividend paid for 13 consecutive years and a share count rising about 4.8% a year. Capital Returns Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.

What changed

No meaningful recorded changes in the stored history.

Risk Intelligence is a core model, Long-Term Potential, Fundamental Momentum, Valuation Intelligence and Capital Returns Intelligence are research models, and Ownership Intelligence is supplemental descriptive evidence. Valuation Intelligence and Capital Returns Intelligence each contribute 0% to the Suggested Investment Score. Nothing here is a recommendation.

Compare DOC with other companies

Appears in

Rule-based membership

Membership means the company satisfied a published rule on the latest research build. It is not a recommendation.

60-Second Brief

Too few stored readings exist for this company to summarise honestly.

Composite discovery model

Suggested Investment Score

Suggested Investment Score

Not currently in the Suggested Investment ranking

Risk Intelligence is unavailable. A composite score is only published when every required input is available for this company. Nothing is estimated to fill a gap, and exclusion from the ranking is not a sell instruction.

COMPOSITE DISCOVERY MODEL — RESEARCH STAGE · Ranking updated September 12, 2026

Researched separately

Valuation Intelligence 65 · Attractive

RESEARCH MODEL

Valuation Intelligence is currently researched separately and does not affect the Suggested Investment Score or daily ranking.

Researched separately

Capital Returns Intelligence 39 · Limited Capital Returns

RESEARCH MODEL

Capital Returns Intelligence is researched separately and contributes 0% to the Suggested Investment Score, the daily rank or any ranking event.

Why this company scores the way it does

This company does not currently hold a stored Suggested Investment Score, so no contribution breakdown can be shown.

Stored snapshots only

What changed

Research-score history available since September 2026.

Stored research history does not yet cover a full 30 days comparison for this company.

A change is reported as meaningful at 8 score points, 5 rank places, or any change of research classification. Nothing here is a recommendation to buy or sell.

Learn the metrics on this page

Plain-English definitions, with the formula and the limitations of each measure.

Fifth research lens · outside the score

Valuation Intelligence

Valuation Intelligence

Is today's price reasonable?

Valuation Intelligence is currently researched separately and does not affect the Suggested Investment Score or daily ranking.

65/ 100

Attractive

RESEARCH MODEL
Excellent coverage

Compared with its history

73

Very Attractive

Is this company expensive or inexpensive compared with its own history?

Compared with peers

68

Attractive

How expensive is this stock compared with similar companies?

Earnings & cash flow

78

Very Attractive

How much financial output does an investor receive relative to the price paid?

Growth-adjusted

32

Expensive

Does the company's growth help justify the valuation investors are paying?

HEALTHPEAK PROPERTIES INC reads 65 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and below comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value.

Price data through September 11, 2026 · Financial data through the quarter ended June 30, 2026

Valuation history

Stored readings only. The dashed line is this company's own median for the selected measure.

Only one stored valuation reading exists so far, so there is nothing to chart yet. Valuation history builds forward from activation rather than being reconstructed.

Current Price / Book 1.8x · own median 2.2x · peer median 2.0x

Valuation is inherently uncertain. A stock that appears inexpensive can continue falling, and a stock that appears expensive can continue rising. Valuation Intelligence provides context about the price investors are paying — it does not predict short-term market movements, and it never produces a fair value, a price target or a buy or sell range. Model VALUATION_INTELLIGENCE_V1.

Sixth research lens · outside the score

Capital Returns Intelligence

Capital Returns Intelligence

How effectively does the company reward shareholders?

Capital Returns Intelligence is researched separately and contributes 0% to the Suggested Investment Score, the daily rank or any ranking event.

39/ 100

Limited Capital Returns

RESEARCH MODEL
Excellent coverage

Dividend Quality

33

Limited Capital Returns

Dividend reliability

Buyback Effectiveness

42

Moderate Capital Returns

Do buybacks actually reduce shares?

The company spends on share repurchases, but much of that activity offsets share issuance rather than materially reducing the share count.

Dilution Control

15

Limited Capital Returns

Is your ownership share protected?

Capital Return Sustainability

62

Favorable Capital Returns

Can the cash flow support it?

Shareholder Yield

44

Moderate Capital Returns

Cash returned versus company value

HEALTHPEAK PROPERTIES INC reads 39 out of 100 on Capital Returns Intelligence (Limited Capital Returns), reflecting a dividend paid for 13 consecutive years and a share count rising about 4.8% a year.

This company spent cash repurchasing stock, but the share count did not fall meaningfully because it also issued shares. Repurchase spending alone did not increase existing shareholders' ownership.

How returned cash was used

Dividends $845.99M · net repurchases $99.96M · total returned $945.94M

Price data through September 11, 2026 · Financial data through the quarter ended June 30, 2026

Capital returns history

Stored readings only. History builds forward from activation rather than being reconstructed.

Only one stored reading exists for this measure so far, so there is nothing to chart yet.

Why higher yield isn't always better

A very high dividend yield may reflect a falling share price or an unsustainable payout. Capital Returns Intelligence emphasizes consistency and sustainability rather than simply rewarding the highest yield.

Why buybacks can be misleading

Announced or gross buyback spending does not always mean shareholders are gaining ownership. Companies can simultaneously issue shares through employee compensation or acquisitions. Suggested Investments therefore considers actual share-count changes alongside repurchase spending.

What these terms mean
Dividend Yield
The annual dividend relative to the current share price.
Payout Ratio
The share of company earnings used to pay dividends.
Free Cash Flow Payout
How much of the company's available cash is being used for dividends.
Share Repurchases
When a company buys back its own stock.
Dilution
When the number of shares increases, reducing each existing share's percentage ownership of the company.
Shareholder Yield
A combined view of dividends and net share repurchases relative to the company's market value.

Capital Returns Intelligence describes how a company returns capital to shareholders. It is not a measure of stock-price performance, it does not predict future returns, and a strong reading is never a recommendation to buy. Dividends and repurchases can be reduced or stopped at any time. Model CAPITAL_RETURNS_INTELLIGENCE_V1, contributing 0% to the Suggested Investment Score.

Stored daily snapshots only

Ranking history

Stored Suggested Investment ranking history
TodayNot rankedNo stored score
30 days agoNot rankedNo stored score
90 days agoNot rankedNo stored score
First suggestedNot yet suggested
Highest rankNot ranked

In the company’s own words

What this company does

Healthpeak Properties, Inc. is a Standard & Poor’s ("S&P") 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States ("U.S."). Our company was originally founded in 1985. We are organized as an umbrella partnership REIT ("UPREIT"). We hold substantially all of our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S.

We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and senior housing real estate. Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the senior housing segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) loans receivable, (ii) a preferred equity investment, and (iii) three other properties . These non-reportable segments have been p resented on a combined basis herein.

On March 1, 2024 (the "Closing Date"), we completed our merger with Physicians Realty Trust (the "Merger"). Subsequent to the Closing Date, the "Combined Company" means Healthpeak and its subsidiaries. As a result of the Merger, we acquired 299 outpatient medical buildings. See Note 3 to the Consolidated Financial Statements for additional information.

In December 2025, we confidentially submitted a draft registration statement on Form S-11 to the SEC relating to the proposed initial public offering (the "Offering" or "Janus Living Offering") of shares of common stock of a newly formed company, Janus Living, Inc. ("Janus Living"), which will be dedicated to senior housing and which intends to elect and qualify to be taxed as a REIT. We will contribute our 34-community, 10,422-unit senior housing portfolio to Janus Living in exchange for a majority ownership interest in Janus Living. Immediately following the Janus Living Offering, we will serve as its external manager and we intend to retain a substantial majority interest in Janus Living, with new public shareholders owning the remaining interest. Based on the anticipated ownership share and terms of the management agreement, we expect to continue to consolidate Janus Living subsequent to the Offering. We expect to complete the Offering in the first half of 2026, subject to market conditions, receipt of regulatory approvals, completion of related financings, completion of the SEC’s review, and other customary conditions.

Quoted from the business section of this company’s 10-K filed February 3, 2026. Read the filing

Four distinct intelligence areas

The IA view

Risk Intelligence

Production core

Insufficient Data

No prior period to compare

Business Quality qualification score from the locked IA Defensive Research Core. Price Risk stays a separate category and is never blended in.

Long-Term Potential

Research model

Insufficient Data

No prior period to compare

Durable business economics and reinvestment characteristics. Independent external validation is pending.

Fundamental Momentum

Research model

Insufficient Data

No prior period to compare

Direction and breadth of change in underlying business fundamentals. Not a price-momentum signal.

Elite Investor Activity

Supplemental

75

Upper range

0 vs Jun 30, 2026

Only 4 tracked managers disclosed a position — treat as limited coverage.

As of Sep 11, 2026

Company intelligence

DOC score history

Each area is measured and reported separately. No combined score exists.

DOC intelligence history from 2023-09-30 to 2026-09-11. Elite Investor Activity 75 on 2026-09-11, unchanged 0 from 75 on 2026-06-30. Each area is reported separately and is never combined into a single score.

Elite Investor Activity 75 as of Sep 11, 2026 (0 vs prior period) · Supplemental

Share price

DOC price history

Closing prices adjusted for splits and dividends, through Sep 11, 2026. Past prices do not indicate future results.

6M change
+23.9%
1Y change
+19.6%
3Y change
+23.6%
5Y change
-23.9%
Max change
-13.7%

Last stored close $20.30 · +19.6% over the selected range · 52 sessions shown

Balanced evidence

Why IA likes it

  • More disclosed holders are new or increasing than reducing or exiting.

Risk and uncertainty

What IA doesn’t like

  • No specific negative evidence is available. This is not evidence of low risk.

What would change our view

  • Business Quality falling below the frozen qualification threshold.
  • Price Risk moving to a less favorable category.
  • A sustained reversal in the Fundamental Momentum research evidence.
  • New material public ownership disclosures.

Public filings · descriptive only

Elite Investor Activity

Reporting holders

1

New holders

1

Increasing

0

Reducing

0

Exiting

0

Coverage

Excellent

Positive disclosed activity · Report period 2016-12-31 · Public 12/22/2023

ManagerChangePortfolio weightRankDisclosed

Insufficient high-confidence manager coverage.

Objective stored changes

What changed

  • Elite Investor Activity

    Elite Investor Consensus strengthened

    Disclosed agreement among tracked managers moved from 67 to 75 for the reporting period ending 2026-06-30.

  • Elite Investor Activity

    Elite Investor Consensus strengthened

    Disclosed agreement among tracked managers moved from 50 to 67 for the reporting period ending 2026-03-31.

  • Elite Investor Activity

    Elite Investor Consensus weakened

    Disclosed agreement among tracked managers moved from 63 to 50 for the reporting period ending 2025-12-31.

  • Elite Investor Activity

    Elite Investor Consensus weakened

    Disclosed agreement among tracked managers moved from 83 to 63 for the reporting period ending 2025-09-30.

  • Elite Investor Activity

    Elite Investor Consensus strengthened

    Disclosed agreement among tracked managers moved from 67 to 83 for the reporting period ending 2025-06-30.

  • Elite Investor Activity

    Elite Investor Consensus weakened

    Disclosed agreement among tracked managers moved from 83 to 67 for the reporting period ending 2025-03-31.

  • Elite Investor Activity

    Elite Investor Consensus weakened

    Disclosed agreement among tracked managers moved from 100 to 83 for the reporting period ending 2024-12-31.

  • Elite Investor Activity

    Tracked managers initiated positions

    3 tracked managers first disclosed a position for the reporting period ending 2024-09-30.

Ownership timeline

No high-confidence public ownership events are available.

General research only. Not personalized advice. Public filings may be delayed, amended, incomplete, or reflect positions that have changed since the reporting date.